Self-reported sleep disturbance is associated with lower CD4 count and 24-h urinary dopamine levels in ethnic minority women living with HIV

Psychoneuroendocrinology

Volumn 38, Issue 11, 2013, Pages 2647-2653

  Seay, Julia S ^a   McIntosh, Roger ^a   Fekete, Erin M ^b   Fletcher, Mary Ann ^c   Kumar, Mahendra ^c   Schneiderman, Neil ^a   Antoni, Michael H ^a  

^a Department of Biology   (United States)

^b UNIVERSITY OF INDIANAPOLIS   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 count; Dopamine; HIV; Sleep

Indexed keywords

DOPAMINE;

ADULT; AFRICAN AMERICAN; AFRICAN CARIBBEAN; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DOPAMINE URINE LEVEL; ETHNIC GROUP; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFECTION RISK; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; PERCEIVED STRESS SCALE; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; SELF REPORT; SLEEP DISORDER; SLEEP QUALITY; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; WOMEN'S HEALTH;

CD4 COUNT; DOPAMINE; HIV; SLEEP;

ADULT; AFRICAN AMERICANS; CARIBBEAN REGION; CD4 LYMPHOCYTE COUNT; DOPAMINE; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; POVERTY; SELF REPORT; SLEEP INITIATION AND MAINTENANCE DISORDERS; VIRAL LOAD;

EID: 84886101126     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.06.022     Document Type: Article

References (51)

1. Antoni M.H., Cruess D.G., Klimas N., Carrico A.W., Maher K.C.S., Lechner S.C., Kumar M., Lutgendorf S., Ironson G., Fletcher M.A., Schneiderman N. Increases in a marker of immune system reconstitution are predated by decreases in 24-h urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic HIV-infected men. J. Psychosom. Res. 2005, 58(1):3-13.
2. Antoni M.H., Carrico A.W., Durán R.E., Spitzer S., Penedo F., Ironson G., Fletcher M.A., Klimas N., Schneiderman N. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom. Med. 2006, 68(1):143-151.
3. Antoni M.H., Pereira D.B., Marion I., Ennis N., Peake M., Rose R., McCalla J., Simon T., Fletcher M.A., Lucci J., Efantis-Potter J., O'Sullivan M.J. Stress management effects on perceived stress and cervical intraepithelial neoplasia in low-income HIV infected women. J. Psychosom. Res. 2008, 65(4):389-401.
4. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51(6):1173-1182.
5. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
6. Buysse D.J., Reynolds C.F.R., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28(2):193-213.
7. Carpenter J.S., Andrykowski M.A. Psychometric evaluation of the Pittsburgh sleep quality index. J. Psychosom. Res. 1998, 45(1):5-13.
8. Carrico A.W., Antoni M.H., Pereira D.B., Fletcher M.A., Klimas N., Lechner S.C., Schneiderman N. Cognitive behavioral stress management effects on mood, social support, and a marker of antiviral immunity are maintained up to 1 year in HIV-infected gay men. Int. J. Behav. Med. 2005, 12(4):218-226.
9. Centers for Disease Control and Prevention.National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention Assessment HIV among Women 2011 August, US Dept of Health and Human Services, Atlanta.
10. Chekhonin V.P., Baklaushev V.P., Kogan B.M., Savchenko E.A., Lebedev S.V., Man'kovskaya I.V., Filatova T.S., Yusupova I.U., Dmitrieva T.B. Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease. Bull. Exp. Biol. Med. 2000, 130(8):805-809.
11. Chesney M.A., Ickovics J.R., Chambers D.B., Gifford A.L., Neidig J., Zwickl B., Wu A.W. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000, 12(3):255-266.
12. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24:385-396.
13. Cohrs S.G.Z., Pohlmann K., Jordan W., Pilz J., Rüther E., Rodenbeck A. Nocturnal urinary dopamine excretion is reduced in otherwise healthy subjects with periodic leg movements in sleep. Neurosci. Lett. 2004, 360(3):161-164.
14. Darko D.F., McCutchan J.A., Kripke D.F., Gillin J.C., Golshan S. Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am. J. Psychiatry 1992, 149(4):514-520.
15. Darko D.F., Miller J.C., Gallen C., White J., Koziol J., Brown S.J., Hayduk R., Atkinson J.H., Assmus J., Munnell D.T., Naitoh P., McCutchan J.A., Mitler M.M. Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(26):12080-12084.
16. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) 1997, American Psychiatric Press, Washington, DC.
17. Fletcher M.A., Maher K., Patarca R., Klimas N. Comparative analysis of lymphocytes in lymph nodes and peripheral blood of patients with chronic fatigue syndrome. J. Chronic Fatigue Syndr. 2000, 7:65-75.
18. Foster S.B., Lu M., Glaze D.G., Reuben J.M., Harris L.L., Cohen E.N., Lee B.N., Zhao E., Paul M.E., Schwarzwald H., McMullen-Jackson C., Clark C., Armstrong F.D., Brouwers P.Y., Miller T.L., Colin A.A., Scott G.B., Shahzeidi S., Willen E.J., Asthana D., Lipshultz S.E., Thompson B.W., Shearer W.T. Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection. Clin. Immunol. 2012, 144(1):13-23.
19. Gómez-González B., Domínguez-Salazar E., Hurtado-Alvarado G., Esqueda-Leon E., Santana-Miranda R., Rojas-Zamorano J.A., Velázquez-Moctezuma J. Role of sleep in the regulation of the immune system and the pituitary hormones. Ann. N.Y. Acad. Sci. 2012, 1261:97-106.
20. Graham J.W., Olchowski A.E., Gilreath T.D. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev. Sci. 2007, 8(3):206-213.
21. Hall M.H., Matthews K.A., Kravitz H.M., Gold E.B., Buysse D.J., Bromberger J.T., Owens J.F., Sowers M. Race and financial strain are independent correlates of sleep in midlife women: the SWAN sleep study. Sleep 2009, 32(1):73-82.
22. Hinz M., Stein A., Uncini T. Validity of urinary monoamine assay sales under the spot baseline urinary neurotransmitter testing marketing model. Int. J. Nephrol. Renovasc. Dis. 2011, 4:101-113.
23. Hornyak M., Trenkwalder C., Kohnen R., Scholz H. Efficacy and safety of dopamine agonists in restless legs syndrome. Sleep Med. 2012, 13(3):228-236.
24. Ironson G., Balbin E., Stieren E., Detz K., Fletcher M.A., Schneiderman N., Kumar M. Perceived stress and norepinephrine predict the effectiveness of response to protease inhibitors in HIV. Int. J. Behav. Med. 2008, 15(3):221-226.
25. Irwin M., McClintick J., Costlow C., Fortner M., White J., Gillin J.C. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996, 10(5):643-653.
26. Jean-Louis G., Magai C., Casimir G.J., Zizi F., Moise F., McKenzie D., Graham Y. Insomnia symptoms in a multiethnic sample of American women. J Womens Health (Larchmt) 2008, 17(1):15-25.
27. Johnson M.O., Chesney M.A., Neilands T.B., Dilworth S.E., Remien R.H., Weinhardt L.S., Wong F.L., Morin S.F. Disparities in reported reasons for not initiating or stopping antiretroviral treatment among a diverse sample of persons living with HIV. J. Gen. Intern. Med. 2009, 24(2):247-251. NIMH Healthy Living Project Team.
28. Kumar A.M., Kumar M., Fernandez J.B., Mellman T.A., Eisdorfer C. A simplified HPLC-ECD technique for measurement of urinary free catecholamines. J. Liq. Chromatogr. Relat. Technol. 1991, 14:3547-3557.
29. Kumar A.M., Fernandez J.B., Singer E.J., Commins D., Waldrop-Valverde D., Ownby R.L., Kumar M. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J. Neurovirol. 2009, 15(3):257-274.
30. Kumar A.M., Ownby R.L., Waldrop-Valverde D., Fernandez B., Kumar M. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J. Neurovirol. 2011, 17(1):26-40.
31. Lee K.A., Portillo C.J., Miramontes H. The influence of sleep and activity patterns on fatigue in women with HIV/AIDS. J. Assoc. Nurses AIDS Care 2001, 12:19-27.
32. Lee K.A., Gay C., Portillo C.J., Coggins T., Davis H., Pullinger C.R., Aouizerat B.E. Types of sleep problems in adults living with HIV/AIDS. J. Clin. Sleep Med. 2012, 8(1):67-75.
33. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom. Med. 2008, 70(5):539-545.
34. Lovasi G.S., Hutson M.A., Guerra M., Neckerman K.M. Built environments and obesity in disadvantaged populations. Epidemiol. Rev. 2009, 31:7-20.
35. Low Y., Preud'homme X., Goforth H.W., Omonuwa T., Krystal A.D. The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study. Sleep 2011, 34(12):1723-1726.
36. Marc D.T., Ailts J.W., Campeau D.C., Bull M.J., Olson K.L. Neurotransmitters excreted in the urine as biomarkers of nervous system activity: validity and clinical applicability. Neurosci. Biobehav. Rev. 2008, 35(3):635-644.
37. Marion I., Antoni M., Pereira D., Wohlgemuth W., Fletcher M.A., Simon T., O'Sullivan M.J. Distress, sleep difficulty, and fatigue in women co-infected with HIV and HPV. Behav. Sleep Med. 2009, 7(3):180-193.
38. Melrose R.J., Tinaz S., Castelo J.M., Courtney M.G., Stern C.E. Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav Sleep Med 2008, 188(2):337-347.
39. Norman S.E., Resnick L., Cohn M.A., Duara R., Herbst J., Berger J.R. Sleep disturbances in HIV-seropositive patients. JAMA 1988, 260(7):922.
40. Phillips K.D., Sowell R.L., Boyd M., Dudgeon W.D., Hand G.A., Group M.-B.R. Sleep quality and health-related quality of life in HIV-infected African-American women of childbearing age. Qual. Life Res. 2005, 14(4):959-970.
41. Power C., Selnes O., Grim J., McArthur J. HIV dementia scale: a rapid screening test. J. Acquir. Immune Defic. Syndr. 1995, 8:273-278.
42. Preacher K.J., Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 2008, 40(3):879-891.
43. Purohit V., Rapaka R., Frankenheim J., Avila A., Sorensen R., Rutter J. National institute on drug abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. J Neurovirol 2013, 19(2):119-122.
44. Rubin D.B. Multiple Imputation for Non-Response in Surveys 1987, J.Wiley & Sons, New York.
45. Sarkar C., Basu B., Chakroborty D., Dasgupta P.S., Basu S. The immunoregulatory role of dopamine: an update. Brain Behav. Immun. 2010, 24(4):525-528.
46. Sasai T., Inoue Y., Matsuura M. Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder. Tohoku J. Exp. Med. 2012, 226(3):177-181.
47. Savard J., Simard S., Ivers H., Morin C.M. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer. Part II: immunologic effects. J. Clin. Oncol. 2005, 23(25):6097-6106.
48. Smith M.T., Huang M.I., Manber R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin. Psychol. Rev. 2005, 25(5):559-592.
49. Weaver K.E., Llabre M.M., Durán R.E., Antoni M.H., Ironson G., Penedo F.J., Schneiderman N. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol. 2005, 24(4):385-392.
50. Wibbeler T., Reichelt D., Husstedt I.W., Evers S. Sleepiness and sleep quality in patients with HIV infection. J. Psychosom. Res. 2012, 72(6):439-442.
51. Yehuda S., Sredni B., Carasso R.L., Kenigsbuch-Sredni D. REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. J. Interferon Cytokine Res. 2009, 29(7):393-398.